Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
William Sietsema authors book on trategic clinical development planning
February 20th, 2005
Kendle International Inc. (KNDL), a clinical research organization, announced that William Sietsema, PhD, vice president, Clinical Regulatory Strategic Planning, has authored a new book titled Strategic Clinical Development Planning: Designing Programs for Winning Products. Available in February 2005 from FDAnews, this 22-chapter book is a guide for biopharmaceutical companies and drug device manufacturers to help them streamline the clinical trials process, ultimately resulting in faster U.S. Food and Drug Administration (FDA) approvals, shorter overall drug development times and cost savings. Clinical development planning is a service...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
